Evidence map›Paper›PMID 39895751›Full record

ArticleACS omega2025

Substrate Specificities of DDX1: A Human DEAD-Box Protein.

Anthony F T Moore, Yepeth Berhie, Isaac S Weislow, Eda Koculi

Abstract read
In one paragraph

Article in ACS omega, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Article
  3. Enzymology of the metazoan tRNA ligase complex: a lifetime in cycles.Cellular and molecular life sciences : CMLS · 2026
    Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Phase-Specific Antibiotic Resistance Mechanisms in anbioRxiv : the preprint server for biology · 2025
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors.

Anthony F T MooreDepartment of Chemistry, University of Central Florida, 4111 Libra Drive, Physical Sciences, Orlando, Florida 32816-2366, United States.
Yepeth BerhieDepartment of Chemistry, University of Central Florida, 4111 Libra Drive, Physical Sciences, Orlando, Florida 32816-2366, United States.
Isaac S WeislowDepartment of Chemistry and Biochemistry, The University of Texas at El Paso, 500 W University Ave, Chemistry and Computer Science, El Paso, Texas 79902-5802, United States.ORCID https://orcid.org/0000-0003-0877-2710
Eda KoculiDepartment of Chemistry and Biochemistry, The University of Texas at El Paso, 500 W University Ave, Chemistry and Computer Science, El Paso, Texas 79902-5802, United States.ORCID https://orcid.org/0000-0001-9477-555X

Funding

Studies of Ribosome BiogenesisR01GM131062 · NIGMS · UNIVERSITY OF TEXAS EL PASO · PI KOCULI, EDA · 2019 to 2023
$1.7M
Targeting oncogenic RNAs with antibodiesR21CA175625 · NCI · UNIVERSITY OF CENTRAL FLORIDA · PI KOCULI, EDA · 2014 to 2015
$302k
NCI NIH HHS R21 CA175625NIGMS NIH HHS R01 GM131062
6 · The paper itself

Abstract

DDX1 is a human DEAD-box RNA helicase involved in various stages of RNA metabolism, from transcription to decay, and is consequently implicated in many human diseases. The nucleotides hydrolyzed by DDX1 and the structures of the nucleic acids upon which it acts in cells remain largely unknown. In this study, we identify the nucleic acid sequences and structures that support DDX1's nucleotide hydrolysis activity and determine its nucleotide hydrolysis specificity. Our data demonstrate that DDX1 hydrolyzes only ATP and deoxy-ATP in the presence of RNA. The ATP hydrolysis activity of DDX1 is stimulated by single-stranded RNA molecules as short as ten nucleotides, a blunt-ended double-stranded RNA, double-stranded RNA/DNA hybrid, and single-stranded DNA. Under our experimental conditions, single-stranded DNA stimulates DDX1's ATPase activity to a smaller extent compared to the other RNA constructs or the RNA/DNA hybrid. Given DDX1's involvement in numerous critical cellular processes and its implication in various human diseases, determining its substrate specificity not only enhances our understanding of its

Identifiers

PMID39895751
PMCPMC11780465

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.